Update on the burden of Campylobacter in developing countries

Current Opinion in Infectious Diseases

Volumn 27, Issue 5, 2014, Pages 444-450

  Platts Mills, James A ^a   Kosek, Margaret ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

burden; Campylobacter; diarrhea; epidemiology; malnutrition

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTHRITIS; BACTERIAL STRAIN; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; DEVELOPING COUNTRY; DISEASE SEVERITY; FIELD STUDY; GASTROENTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; INFLAMMATORY BOWEL DISEASE; LIVESTOCK; MALNUTRITION; PREVALENCE; REVIEW; SEROTYPE; CAMPYLOBACTER COLI; CAMPYLOBACTER INFECTIONS; CHILD; CHILD NUTRITION DISORDERS; COMPLICATION; COST OF ILLNESS; DIARRHEA; DISEASE OUTBREAKS; ECONOMICS; ISOLATION AND PURIFICATION; PATHOGENICITY; TRANSMISSION; WATER SUPPLY;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER COLI; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHILD; CHILD NUTRITION DISORDERS; COST OF ILLNESS; DEVELOPING COUNTRIES; DIARRHEA; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; GASTROENTERITIS; HUMANS; PREVALENCE; WATER SUPPLY;

EID: 84906936102     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000091     Document Type: Review

References (67)

1. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2197-2223.
2. Nichols GL, Richardson JF, Sheppard SK, et al. Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ Open 2012; 2:e001179.
3. Taylor EV, Herman KM, Ailes EC, et al. Common source outbreaks of Campylobacter infection in the USA. Epidemiol Infect 2013; 141:987-996.
4. Taniuchi M, Sobuz SU, Begum S, et al. Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis 2013; 208:1794-1802.
5. Rao MR, Naficy AB, Savarino SJ, et al. Pathogenicity and convalescent excretion of Campylobacter in rural Egyptian children. Am J Epidemiol 2001; 154:166-173.
6. Lee G, Pan W, Penataro Yori P, et al. Symptomatic and asymptomatic Campylobacter infections associated with reduced growth in Peruvian children. PLoS Negl Trop Dis 2013; 7:e2036.
7. Coker AO, Isokpehi RD, Thomas BN, et al. Human campylobacteriosis in developing countries. Emerg Infect Dis 2002; 8:237-244.
8. Lengerh A, Moges F, Unakal C, Anagaw B. Prevalence, associated risk factors and antimicrobial susceptibility pattern of Campylobacter species among under five diarrheic children at Gondar University Hospital, Northwest Ethiopia. BMC Pediatr 2013; 13:82.
9. Crim SM, Iwamoto M, Huang JY, et al. Incidence and trends of infection with pathogens transmitted commonly through food-foodborne diseases active surveillance network, 10 U.S. Sites, 2006-2013. MMWR Morb Mortal Wkly Rep 2014; 63:328-332.
10. Jore S, Viljugrein H, Brun E, et al. Trends in Campylobacter incidence in broilers and humans in six European countries, 1997-2007. Prev Vet Med 2010; 93:33-41.
11. M'Ikanatha NM, Dettinger LA, Perry A, et al. Culturing stool specimens for Campylobacter spp., Pennsylvania, USA. Emerg Infect Dis 2012; 18:484-487.
12. Lastovica AJ, Le Roux E. Efficient isolation of Campylobacter upsaliensis from stools. J Clin Microbiol 2001; 39:4222-4223.
13. Man SM. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 2011; 8:669-685.
14. Bullman S, O'Leary J, Corcoran D, et al. Molecular-based detection of nonculturable and emerging campylobacteria in patients presenting with gastroenteritis. Epidemiol Infect 2012; 140:684-688.
15. Lastovica AJ. Emerging Campylobacter spp.: the tip of the iceberg. Clin Microbiol Newslett 2006; 28:49-56.
16. Granato PA, Chen L, Holiday I, et al. Comparison of premier CAMPY enzyme immunoassay (EIA), ProSpecT Campylobacter EIA, and ImmunoCard STAT! CAMPY tests with culture for laboratory diagnosis of Campylobacter enteric infections. J Clin Microbiol 2010; 48:4022-4027.
17. Giltner CL, Saeki S, Bobenchik AM, Humphries RM. Rapid detection of Campylobacter antigen by enzyme immunoassay leads to increased positivity rates. J Clin Microbiol 2013; 51:618-620.
18. Bessede E, Delcamp A, Sifre E, et al. New methods for detection of campylobacters in stool samples in comparison to culture. J Clin Microbiol 2011; 49:941-944.
19. Ghosh R, Uppal B, Aggarwal P, et al. A comparative study of conventional and molecular techniques in diagnosis of campylobacter gastroenteritis in children. Ann Clin Lab Sci 2014; 44:42-48.
20. Platts-Mills JA, Liu J, Gratz J, et al. Detection of campylobacter in stool and determination of significance by culture, enzyme immunoassay, and PCR in developing countries. J Clin Microbiol 2014; 52:1074-1080.
21. de Boer RF, Ott A, Guren P, et al. Detection of Campylobacter species and Arcobacter butzleri in stool samples by use of real-time multiplex PCR. J Clin Microbiol 2013; 51:253-259.
22. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209-222.
23. Panchalingam S, Antonio M, Hossain A, et al. Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis 2012; 55 (Suppl 4):S294-S302.
24. Calva JJ, Ruiz-Palacios GM, Lopez-Vidal AB, et al. Cohort study of intestinal infection with campylobacter in Mexican children. Lancet 1988; 1:503-506.
25. Houpt ER, Gratz J, Kosek M, et al. Microbiologic methods utilized in the MALED cohort study. Clin Infect Dis 2014; In Press.
26. Platts-Mills J MB, McGrath M, Miller M, Gratz J, Kosek M, Havt A, Samie A, Zaidi A, Kang G, Haque R, Bodhidatta L, Houpt E. Association between enteropathogens, diarrhea and growth in the MAL-ED cohort. 62nd Annual Meeting of the American Society of Tropical Medicine and Hygiene; 2013.
27. Mason J, Iturriza-Gomara M, O'Brien SJ, et al. Campylobacter infection in children in Malawi is common and is frequently associated with enteric virus co-infections. PLoS One 2013; 8:e59663.
28. Lopman B, Kang G. Editorial commentary: in praise of birth cohorts: norovirus infection, disease, and immunity. Clin Infect Dis 2014; 58:492-494.
29. Platts-Mills JA, Gratz J, Mduma E, et al. Association between stool enteropathogen quantity and disease in Tanzanian children using TaqMan array cards: a nested case-control study. Am J Trop Med Hyg 2014; 90:133-138.
30. Platts-Mills JA, Liu J, Houpt ER. New concepts in diagnostics for infectious diarrhea. Mucosal Immunol 2013; 6:876-885.
31. Havelaar AH, van Pelt W, Ang CW, et al. Immunity to Campylobacter: its role in risk assessment and epidemiology. Crit Rev Microbiol 2009; 35:1-22.
32. Mueller I, Schoepflin S, Smith TA, et al. Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children. Proc Natl Acad Sci USA 2012; 109:10030-10035.
33. Kuwabara S, Yuki N. Axonal Guillain-Barre syndrome: concepts and controversies. Lancet Neurol 2013; 12:1180-1188.
34. Islam Z, Jacobs BC, Islam MB, et al. High incidence of Guillain-Barre syndrome in children, Bangladesh. Emerg Infect Dis 2011; 17:1317-1318.
35. Islam Z, Gilbert M, Mohammad QD, et al. Guillain-Barre syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS One 2012; 7:e43976.
36. Porter CK, Choi D, Cash B, et al. Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness. BMC Gastroenterol 2013; 13:46.
37. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 2012; 9:219-230.
38. Riddle MS,Murray JA, Cash BD, et al. Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci 2013; 58:3242-3245.
39. Ajene AN, Fischer Walker CL, Black RE. Enteric pathogens and reactive arthritis: a systematic review of Campylobacter, salmonella and Shigellaassociated reactive arthritis. J Health Popul Nutr 2013; 31:299-307.
40. da Silva Quetz J, Lima IF, Havt A, et al. Campylobacter jejuni and Campylobacter coli in children from communities in Northeastern Brazil: molecular detection and relation to nutritional status. Diagn Microbiol Infect Dis 2010; 67:220-227.
41. Gupta SS, Mohammed MH, Ghosh TS, et al. Metagenome of the gut of a malnourished child. Gut Pathog 2011; 3:7.
42. Masanta WO, Heimesaat MM, Bereswill S, et al. Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol 2013; 2013:526860.
43. Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Clinical manifestations of Campylobacter concisus infection in children. Pediatr Infect Dis J 2013; 32:1194-1198.
44. Labarca JA, Sturgeon J, Borenstein L, et al. Campylobacter upsaliensis: another pathogen for consideration in the United States. Clin Infect Dis 2002; 34:E59-E60.
45. Wagenaar JA, van Bergen MA, Blaser MJ, et al. Campylobacter fetus infections in humans: exposure and disease. Clin Infect Dis 2014; 58:1579-1586.
46. O'Donovan D, Corcoran GD, Lucey B, Sleator RD. Campylobacter ureolyticus: a portrait of the pathogen. Virulence 2014; 5:498-506.
47. Edmonds P, Patton CM, Griffin PM, et al. Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States. J Clin Microbiol 1987; 25:685-691.
48. Lastovica AJ, le Roux E. Efficient isolation of campylobacteria from stools. J Clin Microbiol 2000; 38:2798-2799.
49. Vandenberg O, Cornelius AJ, Souayah H, et al. The role of Epsilonproteobacteria in children with gastroenteritis. Pediatr Infect Dis J 2013; 32:1140-1142.
50. Kaakoush NO, Mitchell HM. Campylobacter concisus-a new player in intestinal disease. Front Cell Infect Microbiol 2012; 2:4.
51. Lin A, Bik EM, Costello EK, et al. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One 2013; 8:e53838.
52. Oberhelman RA, Gilman RH, Sheen P, et al. An intervention-control study of corralling of free-ranging chickens to control Campylobacter infections among children in a Peruvian periurban shantytown. Am J Trop Med Hyg 2006; 74:1054-1059.
53. Black RE, Levine MM, Clements ML, et al. Experimental Campylobacter jejuni infection in humans. J Infect Dis 1988; 157:472-479.
54. Poly F, Read TD, Chen YH, et al. Characterization of two Campylobacter jejuni strains for use in volunteer experimental-infection studies. Infect Immun 2008; 76:5655-5667.
55. Kirkpatrick BD, Lyon CE, Porter CK, et al. Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model. Clin Infect Dis 2013; 57:1106-1113.
56. Monteiro MA, Baqar S, Hall ER, et al. Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni. Infect Immun 2009; 77:1128-1136.
57. Maue AC, Poly F, Guerry P. A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni. Hum Vaccin Immunother 2014; 10: available at http://www.ncbi.nlm.nih.gov/pubmed/24632556.
58. Maue AC, Mohawk KL, Giles DK, et al. The polysaccharide capsule of Campylobacter jejuni modulates the host immune response. Infect Immun 2013; 81:665-672.
59. Pike BL, Guerry P, Poly F. Global distribution of Penner serotypes: a systematic review. PLoS One 2013; 8:e67375.
60. Poly F, Serichatalergs O, Schulman M, et al. Discrimination of major capsular types of Campylobacter jejuni by multiplex PCR. J Clin Microbiol 2011; 49:1750-1757.
61. Ahmed D, Hoque A, Elahi MS, et al. Bacterial aetiology of diarrhoeal diseases and antimicrobial resistance in Dhaka, Bangladesh, 2005-2008. Epidemiol Infect 2012; 140:1678-1684.
62. Mukherjee P, Ramamurthy T, Bhattacharya MK, et al. Campylobacter jejuni in hospitalized patients with diarrhea, Kolkata, India. Emerg Infect Dis 2013; 19:1155-1156.
63. Ghosh R, Uppal B, Aggarwal P, et al. Increasing antimicrobial resistance of Campylobacter jejuni isolated from paediatric diarrhea cases in a tertiary care hospital of New Delhi, India. J Clin Diagn Res 2013; 7:247-249.
64. Pollett S, Rocha C, Zerpa R, et al. Campylobacter antimicrobial resistance in Peru: a ten-year observational study. BMC Infect Dis 2012; 12:193.
65. Mukherjee P, Ramamurthy T, Mitra U, Mukhopadhyay AK. Emergence of highlevel azithromycin resistance in Campylobacter jejuni isolated from Paediatric Diarrhoea cases in Kolkata, India. Antimicrob Agents Chemother 2014; 58:4248.
66. United States Food and Drug Adminstration: 2011 retail meat report: national antimicrobial resistance monitoring system. http://www.fda.gov/ downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/ NationalAntimicrobial ResistanceMonitoringSystem/UCM334834.pdf. [Accessed 8 May 2014.]
67. Love DC, Halden RU, Davis MF, Nachman KE. Feather meal: a previously unrecognized route for reentry into the food supply of multiple pharmaceuticals and personal care products (PPCPs). Environ Sci Technol 2012; 46:3795-3802.